Researchers find high risk of suicide among unaccompanied refugee minors

In a report written on behalf of the Swedish National Board of Health and Welfare, researchers at Karolinska Institutet have concluded that the risk of suicide among unaccompanied refugee minors and young adults in 2017 was nine times higher than the equivalent figure for the same age group in the Swedish population.

Compiling the report presented methodological problems as child refugees do not have Swedish personal identity numbers. Sampling the group has also proven difficult, with unaccompanied refugee minors both arriving during the period in question, but also leaving the country due to rejected asylum applications. For the purpose of the report, researchers have assessed a population of 23,425 unaccompanied asylum-seeking minors and young adults (10-21 years of age) during 2017 and have included only suicides confirmed by the National Board of Forensic Medicine in Sweden.

Researchers found 12 confirmed suicides in the group during 2017, equivalent to 51.2 suicides per 100,000 individuals or nine times that for the same age group in the Swedish population. As each completed suicide is indicative of mental ill-health in a far greater proportion of individuals, the researchers recommend the implementation of acute suicide preventive measures aimed at unaccompanied refugee minors and young adults.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Asimov and RevOpsis Therapeutics sign licensing agreement for high titer multispecific-expressing cell line